• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Hypercholesteremic xanthomatosis in intrahepatic obstructive jaundice after administration of salvarsan].

作者信息

PFEIFFER E F, WIRTZ H

出版信息

Arch Dermatol Syph. 1951;193(2):99-117.

PMID:14924568
Abstract
摘要

相似文献

1
[Hypercholesteremic xanthomatosis in intrahepatic obstructive jaundice after administration of salvarsan].[服用洒尔佛散后肝内阻塞性黄疸中的高胆固醇血症性黄瘤病]
Arch Dermatol Syph. 1951;193(2):99-117.
2
[Syphilis, salvarsan, jaundice; problem of jaundice in the treatment of syphilis].
Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki. 1951;2-3:187-210.
3
INTRAHEPATIC CHOLESTASIS VS. POSTHEPATIC JAUNDICE: METHODS OF DIAGNOSIS, WITH A NOTE ON HYPERCHOLESTEREMIC XANTHOMATOSIS IN A PATIENT WITH CHLORPROMAZINE CHOLESTASIS.肝内胆汁淤积与肝后性黄疸：诊断方法，附氯丙嗪胆汁淤积患者高胆固醇血症性黄瘤病的记录
Med Clin North Am. 1964 Jan;48:53-65. doi: 10.1016/s0025-7125(16)33486-1.
4
Drug reactions characterized by cholestasis associated with intrahepatic biliary tract obstruction.以肝内胆管梗阻相关胆汁淤积为特征的药物反应。
Am J Med. 1957 Dec;23(6):841-5. doi: 10.1016/0002-9343(57)90293-0.
5
Primary hypercholesteremic xanthomatosis; five cases.
Med Bull US Army Eur. 1956 Mar;13(3):60-4; passim.
6
[Familial hypercholesteremic cutaneo-tendinous xanthomatosis. Biochemical study-Therapeutic trials].
Presse Med (1893). 1960 Jan 27;68:143-5.
7
Familial hypercholesteremic xanthomatosis: a preliminary report. I. Clinical, electrocardiographic and laboratory considerations.家族性高胆固醇血症性黄瘤病：初步报告。I. 临床、心电图及实验室相关因素
Am J Med. 1959 Jan;26(1):8-29. doi: 10.1016/0002-9343(59)90323-7.
8
Atherosclerosis and aortic stenosis in hypercholesteremic xanthomatosis.
J Am Med Assoc. 1954 Nov 6;156(10):943-7. doi: 10.1001/jama.1954.02950100019008.
9
[Intrahepatic obstructive jaundice in arsenobenzol therapy].[胂凡纳明治疗中的肝内阻塞性黄疸]
Dtsch Med Wochenschr. 1950 Dec 22;75(51):1713-5. doi: 10.1055/s-0028-1117759.
10
Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. IV. Effects of prolonged administration of heparin on serum lipids in idiopathic hyperlipemia.特发性高脂血症和原发性高胆固醇血症性黄瘤病。IV. 长期给予肝素对特发性高脂血症患者血脂的影响。
AMA Arch Derm. 1955 Feb;71(2):150-7. doi: 10.1001/archderm.1955.01540260008003.

引用本文的文献

1
[Heparin therapy and clinical manifestations of idiopathic hyperlipemic xanthomatosis].[肝素治疗与特发性高脂血症性黄瘤病的临床表现]
Arch Klin Exp Dermatol. 1958;205(5):512-25.
2
[Hyperlipemic xanthomatosis and its treatment with heparin].
Arch Klin Exp Dermatol. 1956;203(5):503-18.

本文引用的文献

1
[Recent knowledge about hepatitis infectiosa (epidemica) and related forms of jaundice].[关于传染性（流行性）肝炎及相关黄疸形式的最新知识]
Klin Wochenschr. 1947 Dec 1;24-25(57-58):904-10. doi: 10.1007/BF01733128.
2
A syringe-transmitted epidemic of infectious hepatitis with observations regarding the incidence and nature of infectious donors.一起由注射器传播的传染性肝炎疫情以及关于感染性供血者的发病率和性质的观察
J Am Med Assoc. 1948 Mar 20;136(12):819-24. doi: 10.1001/jama.1948.02890290009003.
3
Infectious hepatitis inadvertently transmitted with therapeutic malaria.
治疗性疟疾意外传播感染性肝炎。
J Lab Clin Med. 1948 Aug;33(8):998-1001.
4
[Lipoid cell hyperplasia of the spleen and Liver with Chronic bile duct closure].[伴有慢性胆管闭锁的脾脏和肝脏类脂质细胞增生]
Frankf Z Pathol. 1949;61(1):116-25.
5
[A case of intrahepatic occlusive icterus related to the ninth day response to arsenobenzene treatment].[一例与对胂苯治疗的第九日反应相关的肝内阻塞性黄疸病例]
Klin Med Osterr Z Wiss Prakt Med. 1949 Jul 1;4(13):514-7.
6
Extracellular cholesterosis with pulmonary involvement.伴有肺部受累的细胞外胆固醇沉着症。
Arch Derm Syphilol. 1948 Aug;58(2):206-14. doi: 10.1001/archderm.1948.01520210116017.
7
Xanthomatous biliary cirrhosis; a clinical syndrome.黄色瘤性胆汁性肝硬化；一种临床综合征。
Ann Intern Med. 1949 Jan;30(1):121-79. doi: 10.7326/0003-4819-30-1-121.